Washington University School of Medicine in St. Louis | Strategic Alliance Partners

Latest from Washington University School of Medicine in St. Louis


HER2 Mutations Identified as Treatment Targets in Patients With HER2-Negative Breast Cancer

February 05, 2013

Patients with breast cancer who do not exhibit amplifications of the HER2 gene may still have mutations of HER2 that drive the progression of their cancer, suggesting that these mutations could serve as therapeutic targets.